Q-Line Biotech, backed by investor Vikas Khemani, launched its IPO on the NSE Emerge platform Wednesday, seeking to raise up to Rs 214.48 crore for the in-vitro diagnostics and healthcare solutions company. The offering saw strong early subscription.